AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy
Authors: Valenta, R Vrtala, S Focke-Tejkl, M Twardosz, A Swoboda, I Bugajska-Schretter, A Spitzauer, S Kraft, D
Citation: R. Valenta et al., Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy, CL ALLER IM, 16, 2002, pp. 495-517
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice
Authors: Wiedermann, U Herz, U Baier, K Vrtala, S Neuhaus-Steinmetz, U Bohle, B Dekan, G Renz, H Ebner, C Valenta, R Kraft, D
Citation: U. Wiedermann et al., Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice, INT A AL IM, 126(1), 2001, pp. 68-77
A highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5, defined by a human monoclonal IgE antibody
Authors: Flicker, S Vrtala, S Steinberger, P Vangelista, L Kraft, D Valenta, R
Citation: S. Flicker et al., A highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5, defined by a human monoclonal IgE antibody, INT A AL IM, 124(1-3), 2001, pp. 80-84
Induction of blocking antibodies with T cell epitope-containing hypoallergenic recombinant Bet v 1 fragments
Authors: Vrtala, S Akdis, CA Budak, F Akdis, M Blaser, K Kraft, D Valenta, R
Citation: S. Vrtala et al., Induction of blocking antibodies with T cell epitope-containing hypoallergenic recombinant Bet v 1 fragments, INT A AL IM, 124(1-3), 2001, pp. 107-108
Mucosal tolerance induction with hypoallergenic molecules in a murine model of allergic asthma
Authors: Wiedermann, U Herz, U Vrtala, S Neuhaus-Steinmetz, U Renz, H Ebner, C Valenta, R Kraft, D
Citation: U. Wiedermann et al., Mucosal tolerance induction with hypoallergenic molecules in a murine model of allergic asthma, INT A AL IM, 124(1-3), 2001, pp. 391-394
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1
Authors: Vrtala, S Hirtenlehner, K Susani, M Akdis, M Kussebi, F Akdis, CA Blaser, K Hufnagl, P Binder, BR Politou, A Pastore, A Vangelista, L Sperr, WR Semper, H Valent, P Ebner, C Kraft, D Valenta, R
Citation: S. Vrtala et al., Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1, FASEB J, 15(9), 2001, pp. NIL_101-NIL_119
Release of allergen-bearing cytoplasm from hydrated pollen: A mechanism common to a variety of grass (Poaceae) species revealed by electron microscopy
Authors: Grote, M Vrtala, S Niederberger, V Wiermann, R Valenta, R Reichelt, R
Citation: M. Grote et al., Release of allergen-bearing cytoplasm from hydrated pollen: A mechanism common to a variety of grass (Poaceae) species revealed by electron microscopy, J ALLERG CL, 108(1), 2001, pp. 109-115
Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population
Authors: Pauli, G Purohit, A Oster, JP De Blay, F Vrtala, S Niederberger, V Kraft, D Valenta, R
Citation: G. Pauli et al., Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population, CLIN EXP AL, 30(8), 2000, pp. 1076-1084
Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients
Authors: Nopp, A Hallden, G Lundahl, J Johansson, E Vrtala, S Valenta, R Gronneberg, R van Hage-Hamsten, M
Citation: A. Nopp et al., Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients, J ALLERG CL, 106(1), 2000, pp. 101-109
Expulsion of allergen-containing materials from hydrated rye grass (Loliumperenne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy
Authors: Grote, M Vrtala, S Niederberger, V Valenta, R Reichelt, R
Citation: M. Grote et al., Expulsion of allergen-containing materials from hydrated rye grass (Loliumperenne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy, J ALLERG CL, 105(6), 2000, pp. 1140-1145
Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: A study performed with purified recombinant pollen allergens
Authors: Aghayan-Ugurluoglu, R Ball, T Vrtala, S Schweiger, C Kraft, D Valenta, R
Citation: R. Aghayan-ugurluoglu et al., Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: A study performed with purified recombinant pollen allergens, J ALLERG CL, 105(4), 2000, pp. 803-813
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: Molecular, immunological, and structural characterization of the epitope-containing domain
Authors: Flicker, S Vrtala, S Steinberger, P Vangelista, L Bufe, A Petersen, A Ghannadan, M Sperr, WR Valent, P Norderhaug, L Bohle, B Stockinger, H Suphioglu, C Ong, EK Kraft, D Valenta, R
Citation: S. Flicker et al., A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: Molecular, immunological, and structural characterization of the epitope-containing domain, J IMMUNOL, 165(7), 2000, pp. 3849-3859
T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies
Authors: Vrtala, S Akdis, CA Budak, F Akdis, M Blaser, K Kraft, D Valenta, R
Citation: S. Vrtala et al., T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies, J IMMUNOL, 165(11), 2000, pp. 6653-6659
Molecular characterization of human IgG monoclonal antibodies specific forthe major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance theanaphylactic reaction
Authors: Denepoux, S Eibensteiner, PB Steinberger, P Vrtala, S Visco, V Weyer, A Kraft, D Banchereau, J Valenta, R Lebecque, S
Citation: S. Denepoux et al., Molecular characterization of human IgG monoclonal antibodies specific forthe major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance theanaphylactic reaction, FEBS LETTER, 465(1), 2000, pp. 39-46
Genetically engineered and synthetic allergen derivatives: Candidates for vaccination against Type I allergy
Authors: Valenta, R Vrtala, S Focke-Tejkl, M Bugajska-Schretter, A Ball, T Twardosz, A Spitzauer, S Gronlund, H Kraft, D
Citation: R. Valenta et al., Genetically engineered and synthetic allergen derivatives: Candidates for vaccination against Type I allergy, BIOL CHEM, 380(7-8), 1999, pp. 815-824
The importance of recombinant allergens for diagnosis and therapy of IgE-mediated allergies
Authors: Kraft, D Ferreira, F Vrtala, S Breiteneder, H Ebner, C Valenta, R Susani, M Breitenbach, M Scheiner, O
Citation: D. Kraft et al., The importance of recombinant allergens for diagnosis and therapy of IgE-mediated allergies, INT A AL IM, 118(2-4), 1999, pp. 171-176
Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives
Authors: Pauli, G Purohit, A Oster, JP de Blay, F Vrtala, S Niederberger, V Kraft, D Valenta, R
Citation: G. Pauli et al., Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives, INT A AL IM, 118(2-4), 1999, pp. 216-217
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy
Authors: Vrtala, S Hirtenlehner, K Susani, M Hufnagl, P Binder, BR Vangelista, L Pastore, A Sperr, WR Valent, P Ebner, C Kraft, D Valenta, R
Citation: S. Vrtala et al., Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy, INT A AL IM, 118(2-4), 1999, pp. 218-219
An immunoglobulin-like fold in a major plant allergen: the solution structure of Phl p 2 from timothy grass pollen
Authors: De Marino, S Morelli, MAC Fraternali, F Tamborini, E Musco, G Vrtala, S Dolecek, C Arosio, P Valenta, R Pastore, A
Citation: S. De Marino et al., An immunoglobulin-like fold in a major plant allergen: the solution structure of Phl p 2 from timothy grass pollen, STRUCT F D, 7(8), 1999, pp. 943-952
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7
Authors: Niederberger, V Hayek, B Vrtala, S Laffer, S Twardosz, A Vangelista, L Sperr, WR Valent, P Rumpold, H Kraft, D Ehrenberger, K Valenta, R Spitzauer, S
Citation: V. Niederberger et al., Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7, FASEB J, 13(8), 1999, pp. 843-856
pET-prof, a plasmid for high-level expression of recombinant peptides fused to a birch profilin-derived hexadecapeptide tag: A system for the detection and presentation of recombinant antigens
Authors: Pandjaitan, B Eibensteiner, PB Vrtala, S Hayek, B Grote, M Reichelt, R Rumpold, H Valenta, R Spitzauer, S
Citation: B. Pandjaitan et al., pET-prof, a plasmid for high-level expression of recombinant peptides fused to a birch profilin-derived hexadecapeptide tag: A system for the detection and presentation of recombinant antigens, GENE, 237(2), 1999, pp. 333-342
Recombinant allergens for specific immunotherapy
Authors: Valenta, R Vrtala, S
Citation: R. Valenta et S. Vrtala, Recombinant allergens for specific immunotherapy, ALLERGY, 54, 1999, pp. 43-44
Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix oftwo recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season
Authors: van Hage-Hamsten, M Kronqvist, M Zetterstrom, O Johansson, E Niederberger, V Vrtala, S Gronlund, H Gronneberg, R Valenta, R
Citation: M. Van Hage-hamsten et al., Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix oftwo recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season, J ALLERG CL, 104(5), 1999, pp. 969-977
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from timothy grass (Phleum pratense) pollen
Authors: Vrtala, S Fischer, S Grote, M Vangelista, L Pastore, A Sperr, WR Valent, P Reichelt, R Kraft, D Valenta, R
Citation: S. Vrtala et al., Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from timothy grass (Phleum pratense) pollen, J IMMUNOL, 163(10), 1999, pp. 5489-5496
Molecular characterization of allergens, their B-cell epitopes and allergen-specific antibodies for allergy prevention and treatment
Authors: Valenta, R Vrtala, S Ball, T Laffer, S Eibensteiner, P Steinberger, P Flicker, S Fischer, S Mittermann, I Spitzauer, S Kraft, D
Citation: R. Valenta et al., Molecular characterization of allergens, their B-cell epitopes and allergen-specific antibodies for allergy prevention and treatment, LUNG BIOL H, 136, 1999, pp. 313-325
Risultati: 1-25 | 26-26